Filana Therapeutics, Inc. Earnings

The next earnings date for Filana Therapeutics, Inc. is August 12, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Filana Therapeutics, Inc. Earnings

Report DateEstimated Earnings Per Share
08/12/2026$-0.36

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Filana Therapeutics, Inc. Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/06/2026---------
03/03/2026After Market------
11/12/2025Before Market$-0.2220.12%
07/30/2025---------
05/08/2025Before Market$-0.48---
03/03/2025Before Market$-0.5714.68%
11/07/2024Before Market$-0.5835.38%
08/08/2024Before Market$0.13131.86%
05/10/2024After Market$-0.438.35%
02/28/2024Before Market$-0.505.73%
11/07/2023Before Market$-0.6122.83%
08/03/2023Before Market$-0.63-4.69%
05/01/2023Before Market$-0.58-2.46%
02/28/2023Before Market$-0.4717.72%
11/07/2022Before Market$-0.51-4.70%
08/03/2022Before Market$-0.48-8.79%
05/05/2022Before Market$-0.44-3.95%
02/28/2022After Market$-0.35-2.43%
11/10/2021Before Market$-0.24-56.86%
08/03/2021Before Market$-0.130.46%
04/21/2021Before Market$-0.0911.76%
03/23/2021Before Market$-0.09-85.57%
11/09/2020Before Market$-0.0611.76%
08/12/2020Before Market$-0.0518.30%
03/26/2020Before Market$-0.0839.67%
10/29/2019Before Market$-0.0470.95%
08/12/2019Before Market$-0.0643.98%
08/09/2017Before Market$-0.64-33.50%
04/25/2017After Market$-0.421.96%
02/17/2017Before Market$-0.4226.47%
10/20/2016Before Market$-0.5612.85%
07/19/2016After Market$-0.4950.98%
05/05/2016After Market$-0.91-27.45%
02/04/2014Before Market$5.047,158.82%
10/31/2013Before Market$-0.14-96.08%
08/01/2013Before Market$-0.071.96%
04/24/2013Before Market$-0.071.96%
02/06/2013Before Market$-0.28-161.44%
11/08/2012Before Market$-0.21-488.24%
08/02/2012Before Market$0100.00%
05/08/2012Before Market$0100.00%
02/09/2012Before Market$-0.0750.98%
11/03/2011Before Market$-0.141.96%
08/04/2011Before Market$-0.21-47.06%
04/27/2011Before Market$0100.00%
10/28/2010Before Market$-0.14-128.01%
07/28/2010Before Market$-0.1434.64%
01/28/2010Before Market$-0.0775.49%
10/29/2009Before Market$-0.211.96%
08/04/2009Before Market$0100.00%
04/30/2009Before Market$-0.28-74.24%
02/05/2009Before Market$-0.21-151.14%
10/29/2008Before Market$2.45-4.15%
07/30/2008Before Market$-0.14-114.42%
05/07/2008Before Market$0.4211.29%
02/07/2008Before Market$0.14-50.98%
11/01/2007Before Market$0.49-4.69%
08/09/2007Before Market$0.49243.14%
05/02/2007Before Market$1.961,472.55%
02/05/2007Before Market$-0.91-1,161.84%
10/25/2006Before Market$1.47252.94%
08/09/2006Before Market$0.21-23.27%
05/04/2006After Market$0.14-60.78%
01/17/2006Before Market$-0.4962.29%
11/02/2005After Market$-1.4020.94%
07/26/2005Before Market$-1.61-0.97%
04/21/2005Before Market$-1.4015.27%
01/26/2005Before Market$-1.5413.15%
10/19/2004Before Market$-1.825.59%
07/20/2004Before Market$-1.8212.10%
04/22/2004Before Market$-2.03-3.39%
01/27/2004Before Market$-1.331.96%
10/21/2003Before Market$-1.474.24%
07/22/2003After Market$-1.127.73%
04/24/2003After Market$-1.19-2.04%
02/25/2003After Market$-1.33-0.69%
11/07/2002After Market$-0.7748.65%
08/08/2002After Market$-0.9833.05%
05/09/2002After Market$-1.0525.22%
03/12/2002After Market$-1.1912.28%
11/08/2001After Market$-0.9151.91%
08/09/2001After Market$-0.8448.85%
05/10/2001After Market$-0.6363.99%
03/08/2001After Market$-0.7758.52%
11/09/2000---$-1.5415.42%

More About Filana Therapeutics, Inc.

Country
USA
Full Time Employees
17

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.

Filana Therapeutics, Inc. Earnings” Can Refer to the Filana Therapeutics, Inc. Earnings Date

Some people say “Filana Therapeutics, Inc. earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Filana Therapeutics, Inc. position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Filana Therapeutics, Inc. Stock on the Earnings Date

If you own Filana Therapeutics, Inc. stock (FLNA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Filana Therapeutics, Inc. might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Filana Therapeutics, Inc. shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Filana Therapeutics, Inc. Earnings

You can contact us any time if you would like to ask questions about Filana Therapeutics, Inc. earnings or anything else related to the stock market.